Fondazione Policlinico Universitario "A. Gemelli" IRCCS Trials

Fondazione Policlinico Universitario "A. Gemelli" IRCCS	Welcome, Profile Billing Logout

62 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Fagotti, Anna

OVHIPEC-2, NCT03772028 / 2018-003346-17: Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Recruiting

538

Europe, US

cisplatin

The Netherlands Cancer Institute

Ovarian Cancer

04/25

04/26

NCT04763421: A Prospective, Single-Arm Multi-Center Study of the ENSEAL X1 Curved Jaw Tissue Sealer in Select Procedures

Completed

N/A

145

Europe, US

ENSEAL X1 Curved Jaw

Ethicon Endo-Surgery

Upper GI; Lower GI; Gynecological

08/23

09/23

LASH, NCT06416748: Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer

Recruiting

N/A

974

Europe

Minimally invasive simple hysterectomy, simple hysterectomy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancer, Cervix Cancer

07/27

07/30

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Alletti, Salvatore Gueli

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Scambia, Giovanni

NCT04460807 / 2018-000693-30: Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Terminated

Europe

Exemestane, Mestane, Placebo oral tablet

Ente Ospedaliero Ospedali Galliera, Istituto Di Ricerche Farmacologiche Mario Negri, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Federation of Italian Cooperative Oncology Groups

Ovarian Cancer

04/23

NCT02584478 / 2021-003871-32: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Active, not recruiting

294

Europe, US, RoW

AL3818, Anlotinib Hydrochloride, Anlotinib, Catequentinib, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD), Topotecan, Daily Topotecan, Weekly Topotecan, Carboplatin, Paraplatin, Taxol

Advenchen Laboratories, LLC, Advenchen Laboratories, LLC

Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Cervical Carcinoma

10/24

12/24

FLORA-4, NCT04498117 / 2020-002270-26: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Active, not recruiting

615

Europe, Canada, US, RoW

Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo

CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms

09/25

08/27

NUVOLA, NCT04261465: TRIAL Open-label Multicentre Study

Recruiting

Europe

Olaparib, Lynparza, Paclitaxel, Carboplatin

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

High Grade Serous Ovarian Cancer

12/20

12/22

PYNNACLE, NCT04585750: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

Recruiting

1/2

230

Europe, US, RoW

rezatapopt, PC14586, pembrolizumab, KEYTRUDA®, MK-3475, KEYNOTE-D79, MK-3475-D79

PMV Pharmaceuticals, Inc, Merck Sharp & Dohme LLC

Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor, Lung Cancer, Ovarian Cancer, Endometrial Cancer, Prostate Cancer, Colorectal Cancer, Breast Cancer, Other Cancer, Locally Advanced, Head and Neck Cancer, Gall Bladder Cancer, Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Small Cell Lung Carcinoma, NSCLC, NSCLC (Non-small Cell Lung Cancer), SCLC, Non-Small Cell Lung Carcinoma, Triple Negative Breast Cancer, TNBC, HER2+ Breast Cancer, Non-Small Cell Lung Cancer, ER/PR Positive Breast Cancer, HER2- Breast Cancer, HER2-positive Breast Cancer, HER2-negative Breast Cancer, ER/PR(+), Her2(-) Breast Cancer

03/26

07/26

GO-VAC, NCT04584957: Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)

Active, not recruiting

N/A

196

Europe

VAC therapy

Catholic University of the Sacred Heart

Wound Infection, Gynecologic Cancer

09/21

MYLUNAR, NCT04123158: MYometrial Lesion UltrasouNd And mRi

Completed

N/A

2353

Europe

Ultrasound, MRI

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Prof. Antonia Testa, Dr. Daniela Romualdi, Dr. Francesca Ciccarone

Sarcoma Uterus

12/23

CLESS, NCT04178876: Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( )

Recruiting

N/A

Europe

ethanol sclerotherapy, stripping technique

Catholic University of the Sacred Heart

Endometrioma

11/22

06/23

FPG-500, NCT06020625: Mutational Oncology in Clinical Practice

Recruiting

N/A

20000

Europe

Diagnostic Test

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Genome Instability, Genetic Predisposition to Disease, Gene Rearrangement

05/23

01/32

NCT04291612: Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Recruiting

N/A

1400

Europe, US, RoW

Physical exam

Memorial Sloan Kettering Cancer Center

Endometrial Cancer, Endometrioid Adenocarcinoma, Endometrial Cancer Stage I

02/25

R-LYNUS, NCT06621823: Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies

Recruiting

N/A

160

Europe

image-guided surgery technique

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lymph Node Metastasis, Gynecologic Cancer

12/24

05/26

G-AYA, NCT06594471: Comprehensive Assessment of Clinical Characteristics and Outcomes of Gemelli Adolescents and Young Adults

Not yet recruiting

N/A

500

Europe

Questionnaire on late-term physical effects, Questionnaire on sexual and reproductive health outcomes, Questionnaire on psychological outcomes, Questionnaire on social outcomes

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Gynecologic Cancer

09/39

03/40

LYSE, NCT06619002: Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies

Recruiting

N/A

100

Europe

Sentinel lymph node sampling, sentinel lymph node detection, sentinel lymph node dissection, sentinel lymph node biopsy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IHU Strasbourg, University Hospital, Strasbourg

Endometrial Cancer, Cervical Cancer, Deep Learning, Artificial Intelligence

09/26

09/27

LASH, NCT06416748: Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer

Recruiting

N/A

974

Europe

Minimally invasive simple hysterectomy, simple hysterectomy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancer, Cervix Cancer

07/27

07/30

GEN&RARE, NCT06926127: Genomic Profiling of Genetic and Rare Diseases

Recruiting

N/A

1500

Europe

Whole Exome Sequencing (WES)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rare Diseases, Genetic Disease

04/26

02/30

Immuno-Gyn, NCT06737640: Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer

Not yet recruiting

N/A

Europe

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancer, Endometrial Cancer

12/25

12/26

SOLAR, NCT06832397: Detection of Peritoneal Metastases by Diagnostic LAparoscopy in Patients With Locally Advanced Cervical Carcinoma

Not yet recruiting

N/A

120

Europe

Diagnostic laparoscopy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancer

02/28

02/31

STORY, NCT06802198: A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes

Not yet recruiting

N/A

500

Europe

total hysterectomy, subtotal hysterectomy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Fibroid Uterus, Metrorrhagia, Adenomyosis, Benign Gynecologic Neoplasm, Endometriosis, Abnormal Uterine Bleeding

02/28

02/30

IMMUNO_ASSAY, NCT06797479: Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.

Not yet recruiting

N/A

Blood samples for the analysis of sildenafil in plasma

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Gynecological Cancer, Immunotherapy

03/30

12/30

MIPEX, NCT06867445: Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence

Recruiting

N/A

Europe

Minimally invasive pelvic exenteration

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancers, Vaginal Cancers

03/28

03/31

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Vizzielli, Giuseppe

ENDO-3, NCT04073706: Sentinel Node Biopsy in Endometrial Cancer

Recruiting

760

Europe, US, RoW

TH BSO with SNB Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted, TH BSO without retroperitoneal node dissection Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted

Queensland Centre for Gynaecological Cancer, The University of Queensland

Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery

01/31

02/31

NCT04291612: Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Recruiting

N/A

1400

Europe, US, RoW

Physical exam

Memorial Sloan Kettering Cancer Center

Endometrial Cancer, Endometrioid Adenocarcinoma, Endometrial Cancer Stage I

02/25

ENDOmiRNA, NCT06414720: Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy

Recruiting

N/A

Europe

Dienogest 2 MG, zafrilla, devicius, endodien, visanne

University of Udine

Endometriosis

12/25

NCT06689956: Outcomes of Low-Risk Endometrial Cancer with Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective, Multicenter, Cohort Study

Recruiting

N/A

212

Europe, Canada, US, RoW

Non-Interventional Study

Mayo Clinic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023

10/29

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Sette, Claudio

GlioPDO, NCT06781372: Patient's Derived Organoids for Drug Screening in Glioblastoma

Not yet recruiting

N/A

100

Europe

Development and characterization of PDOs, Evaluation of the effects of epigenetic and splicing inhibitors on viability and gene expression signatures of GBM PDOs and GSCs

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Glioblastoma, Glioblastoma Multiforme (GBM), Glioblastoma Multiforme, Adult

01/28

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Nero, Camilla

PICTURE, NCT06085404: Patients Derived Organoids in Ovarian Cancer

Recruiting

N/A

Europe

Blood sample, Tumor Biopsy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Ovarian Cancer

04/25

11/25

TOSCA, NCT06065358: Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction

Recruiting

N/A

Europe

Tumor biopsy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Ovarian Cancer

10/23

12/23

PROGENITOR, NCT05953883: Proteogenomic Signatures Analysis In Ovarian Cancer

Active, not recruiting

N/A

Europe

Tumor and blood sample

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Ovarian Cancer

11/23

03/25

PROBE II, NCT05769517: PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Recruiting

N/A

1300

Europe

Germinal BRCA

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

BRCA Mutation, Ovarian Cancer, Ultrasound Therapy; Complications

04/24

05/26

SPEED, NCT06071286: SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS

Recruiting

N/A

Europe

Blood samples

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Ovarian Cancer

10/25

10/26

GEN&RARE, NCT06926127: Genomic Profiling of Genetic and Rare Diseases

Recruiting

N/A

1500

Europe

Whole Exome Sequencing (WES)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rare Diseases, Genetic Disease

04/26

02/30

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Cesari, Eleonari

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Pieraccioli, Marco

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Bottoni, Carolina

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Conte, Carmine

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Loverro, Matteo

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Iacovelli, Roberto

SELECTIO-UC, NCT06820255: DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.

Recruiting

135

Europe

Platinum + Gemcitabine, Avelumab first-line maintenance, NGS test for DDR alterations

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable, Upper Tract Urothelial Cancer

01/26

01/27

ITALIC-RCC, NCT06903312: Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

Not yet recruiting

409

Deferred Cytoreductive Nephrectomy + medical treatment, Radiotherapy + medical treatment, Medical therapy, Standard of Care (SOC)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, AIRC (Italian Association for Cancer Research)

Renal Cell Cancer, Kidney Neoplasm, Immunotherapy, Kidney Cancer, Surgery Programmed, Radiotherapy

10/27

04/28

CYCLONE 3, NCT05288166: A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

Active, not recruiting

900

Europe, Canada, Japan, US, RoW

Abemaciclib, LY2835219, Abiraterone, Prednisone or Prednisolone, Placebo for Abemaciclib

Eli Lilly and Company

Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Androgens, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Abiraterone Acetate, Steroid Synthesis Inhibitors, Cytochrome P-450, Enzyme Inhibitors, Prednisone, Prednisolone, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6

02/24

10/27

KEYNOTE-D74, NCT05911295: Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Recruiting

400

Europe, Canada, US, RoW

disitamab vedotin, RC48, RC48-ADC, pembrolizumab, KEYTRUDA®, gemcitabine, Gemzar, cisplatin, carboplatin

Seagen Inc., RemeGen Co., Ltd., Merck Sharp & Dohme LLC

Urothelial Carcinoma

06/26

04/29

PEACE6-Unfit, NCT04916613 / 2020-003663-26: ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Recruiting

300

Europe

Darolutamide 300 mg, Nubeqa®, Placebo, Androgen deprivation therapy, ADT

UNICANCER, Bayer

Prostate Cancer Metastatic

03/28

09/37

TIDE-A, NCT04698213: Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma

Recruiting

Europe

Axitinib Oral Tablet, Avelumab

Consorzio Oncotech, Clinical Research Technology S.r.l.

Renal Carcinoma Metastatic

09/23

10/24

CNN-BC, NCT05203913: Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer

Recruiting

Europe

Nivolumab, Opdivo, Nab paclitaxel, Abraxane, Cisplatin, CDDP, Radiotherapy, RT

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Muscle-Invasive Bladder Carcinoma

12/25

06/26

GDFather-NEO, NCT06059547 / 2022-002816-22: Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer

Active, not recruiting

Europe

Nivolumab, Visugromab (CTL-002), Placebo

CatalYm GmbH, CatalYm GmbH

Bladder Cancer, Adult Solid Tumor

08/25

09/26

PE-PE, NCT05578664 / 2022-001077-30: Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer

Recruiting

Europe

Pembrolizumab injection plus metastasis directed treatment (surgery or RT), Tumor resection or RT

Consorzio Oncotech, MERCK SHARP & DOHME LLC.

Oligometastatic Renal Cell Carcinoma

10/24

10/25

KEYNOTE-D78, NCT04879329: A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Recruiting

372

Europe, Canada, Japan, US, RoW

disitamab vedotin, RC48-ADC, pembrolizumab, KEYTRUDA®

Seagen, a wholly owned subsidiary of Pfizer, Merck Sharp & Dohme LLC

Urothelial Carcinoma

12/26

06/28

AxIn, NCT05817903 / 2022-001150-35: Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

Recruiting

118

Europe

Axitinib, Inlyta, Nivolumab

Consorzio Oncotech, Pfizer

Metastatic Renal Cell Carcinoma

04/26

04/27

SkinHealthOnco, NCT05878964: Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

Recruiting

N/A

420

Europe

EQ-5D-5L questionnaire, FACT-G (Functional Assessment of Cancer Therapy - General), FACT-EGFRI-18 (Functional Assessment of Cancer Therapy - Epidermal Growth Factor Inhibitors 18 Item)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lung Cancer, Breast Cancer, Kidney Cancer, Bladder Cancer, Gastric Cancer, Skin Cancer, Melanoma, Head Neck Cancer

07/25

09/25

PSA-DEEP02, NCT06652607: PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer

Recruiting

N/A

152

Europe

Enzalutamide, Apalutamide (Erleada™) 60 mg or 240 mg tablets, Darolutamide (Nubeqa®) 300 mg tablets, Taxotere (docetaxel), Abiraterone acetate + Prednisone or Prednisolone

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Prostate Cancer, Metastatic Cancer, Castrate Sensitive Prostate Cancer

11/26

04/28

Laurenti, Patrizia

CoVFlu, NCT05781191: Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine

Completed

N/A

8231

Europe

COMIRNATY, FLUAD TETRA, FLUCELVAX TETRA, FLUARIX TETRA

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Influenza, COVID-19

12/21

CeVOT-Her-Zo, NCT06334861: Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine Coverage

Completed

N/A

178

Europe

Herpes Zoster adjuvanted recombinant vaccine

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Herpes Zoster

05/24

07/24

SaniPhone, NCT06194903: Randomized Pilot Study Evaluating Isopropyl Alcohol and UVC Rays in Disinfection of Cell Phones

Completed

N/A

Europe

isopropyl alcohol wipes, UVC box

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cross Infection

03/24

04/24

CAREVAX, NCT06127563: Caring for Frail Patients Through Vaccination

Active, not recruiting

N/A

1500

Europe

creation of a clinical pathway to increase vaccination coverage in frail patients

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Vaccination Uptake

07/25

07/27

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Fagotti, Anna

OVHIPEC-2, NCT03772028 / 2018-003346-17: Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Recruiting

538

Europe, US

cisplatin

The Netherlands Cancer Institute

Ovarian Cancer

04/25

04/26

NCT04763421: A Prospective, Single-Arm Multi-Center Study of the ENSEAL X1 Curved Jaw Tissue Sealer in Select Procedures

Completed

N/A

145

Europe, US

ENSEAL X1 Curved Jaw

Ethicon Endo-Surgery

Upper GI; Lower GI; Gynecological

08/23

09/23

LASH, NCT06416748: Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer

Recruiting

N/A

974

Europe

Minimally invasive simple hysterectomy, simple hysterectomy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancer, Cervix Cancer

07/27

07/30

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Alletti, Salvatore Gueli

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Scambia, Giovanni

NCT04460807 / 2018-000693-30: Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Terminated

Europe

Exemestane, Mestane, Placebo oral tablet

Ente Ospedaliero Ospedali Galliera, Istituto Di Ricerche Farmacologiche Mario Negri, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Federation of Italian Cooperative Oncology Groups

Ovarian Cancer

04/23

Active, not recruiting

294

Europe, US, RoW

AL3818, Anlotinib Hydrochloride, Anlotinib, Catequentinib, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD), Topotecan, Daily Topotecan, Weekly Topotecan, Carboplatin, Paraplatin, Taxol

Advenchen Laboratories, LLC, Advenchen Laboratories, LLC

Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Cervical Carcinoma

10/24

12/24

FLORA-4, NCT04498117 / 2020-002270-26: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Active, not recruiting

615

Europe, Canada, US, RoW

Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo

CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd

09/25

08/27

NUVOLA, NCT04261465: TRIAL Open-label Multicentre Study

Recruiting

Europe

Olaparib, Lynparza, Paclitaxel, Carboplatin

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

High Grade Serous Ovarian Cancer

12/20

12/22

PYNNACLE, NCT04585750: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

Recruiting

1/2

230

Europe, US, RoW

rezatapopt, PC14586, pembrolizumab, KEYTRUDA®, MK-3475, KEYNOTE-D79, MK-3475-D79

PMV Pharmaceuticals, Inc, Merck Sharp & Dohme LLC

03/26

07/26

GO-VAC, NCT04584957: Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)

Active, not recruiting

N/A

196

Europe

VAC therapy

Catholic University of the Sacred Heart

Wound Infection, Gynecologic Cancer

09/21

MYLUNAR, NCT04123158: MYometrial Lesion UltrasouNd And mRi

Completed

N/A

2353

Europe

Ultrasound, MRI

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Prof. Antonia Testa, Dr. Daniela Romualdi, Dr. Francesca Ciccarone

Sarcoma Uterus

12/23

CLESS, NCT04178876: Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( )

Recruiting

N/A

Europe

ethanol sclerotherapy, stripping technique

Catholic University of the Sacred Heart

Endometrioma

11/22

06/23

FPG-500, NCT06020625: Mutational Oncology in Clinical Practice

Recruiting

N/A

20000

Europe

Diagnostic Test

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Genome Instability, Genetic Predisposition to Disease, Gene Rearrangement

05/23

01/32

NCT04291612: Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Recruiting

N/A

1400

Europe, US, RoW

Physical exam

Memorial Sloan Kettering Cancer Center

Endometrial Cancer, Endometrioid Adenocarcinoma, Endometrial Cancer Stage I

02/25

R-LYNUS, NCT06621823: Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies

Recruiting

N/A

160

Europe

image-guided surgery technique

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lymph Node Metastasis, Gynecologic Cancer

12/24

05/26

G-AYA, NCT06594471: Comprehensive Assessment of Clinical Characteristics and Outcomes of Gemelli Adolescents and Young Adults

Not yet recruiting

N/A

500

Europe

Questionnaire on late-term physical effects, Questionnaire on sexual and reproductive health outcomes, Questionnaire on psychological outcomes, Questionnaire on social outcomes

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Gynecologic Cancer

09/39

03/40

Recruiting

N/A

100

Europe

Sentinel lymph node sampling, sentinel lymph node detection, sentinel lymph node dissection, sentinel lymph node biopsy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IHU Strasbourg, University Hospital, Strasbourg

Endometrial Cancer, Cervical Cancer, Deep Learning, Artificial Intelligence

09/26

09/27

LASH, NCT06416748: Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer

Recruiting

N/A

974

Europe

Minimally invasive simple hysterectomy, simple hysterectomy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancer, Cervix Cancer

07/27

07/30

GEN&RARE, NCT06926127: Genomic Profiling of Genetic and Rare Diseases

Recruiting

N/A

1500

Europe

Whole Exome Sequencing (WES)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rare Diseases, Genetic Disease

04/26

02/30

Immuno-Gyn, NCT06737640: Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer

Not yet recruiting

N/A

Europe

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancer, Endometrial Cancer

12/25

12/26

SOLAR, NCT06832397: Detection of Peritoneal Metastases by Diagnostic LAparoscopy in Patients With Locally Advanced Cervical Carcinoma

Not yet recruiting

N/A

120

Europe

Diagnostic laparoscopy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancer

02/28

02/31

STORY, NCT06802198: A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes

Not yet recruiting

N/A

500

Europe

total hysterectomy, subtotal hysterectomy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Fibroid Uterus, Metrorrhagia, Adenomyosis, Benign Gynecologic Neoplasm, Endometriosis, Abnormal Uterine Bleeding

02/28

02/30

IMMUNO_ASSAY, NCT06797479: Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.

Not yet recruiting

N/A

Blood samples for the analysis of sildenafil in plasma

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Gynecological Cancer, Immunotherapy

03/30

12/30

MIPEX, NCT06867445: Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence

Recruiting

N/A

Europe

Minimally invasive pelvic exenteration

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical Cancers, Vaginal Cancers

03/28

03/31

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Vizzielli, Giuseppe

ENDO-3, NCT04073706: Sentinel Node Biopsy in Endometrial Cancer

Recruiting

760

Europe, US, RoW

Queensland Centre for Gynaecological Cancer, The University of Queensland

Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery

01/31

02/31

NCT04291612: Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Recruiting

N/A

1400

Europe, US, RoW

Physical exam

Memorial Sloan Kettering Cancer Center

Endometrial Cancer, Endometrioid Adenocarcinoma, Endometrial Cancer Stage I

02/25

ENDOmiRNA, NCT06414720: Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy

Recruiting

N/A

Europe

Dienogest 2 MG, zafrilla, devicius, endodien, visanne

University of Udine

Endometriosis

12/25

NCT06689956: Outcomes of Low-Risk Endometrial Cancer with Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective, Multicenter, Cohort Study

Recruiting

N/A

212

Europe, Canada, US, RoW

Non-Interventional Study

Mayo Clinic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023

10/29

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Sette, Claudio

GlioPDO, NCT06781372: Patient's Derived Organoids for Drug Screening in Glioblastoma

Not yet recruiting

N/A

100

Europe

Development and characterization of PDOs, Evaluation of the effects of epigenetic and splicing inhibitors on viability and gene expression signatures of GBM PDOs and GSCs

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Glioblastoma, Glioblastoma Multiforme (GBM), Glioblastoma Multiforme, Adult

01/28

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Nero, Camilla

PICTURE, NCT06085404: Patients Derived Organoids in Ovarian Cancer

Recruiting

N/A

Europe

Blood sample, Tumor Biopsy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Ovarian Cancer

04/25

11/25

TOSCA, NCT06065358: Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction

Recruiting

N/A

Europe

Tumor biopsy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Ovarian Cancer

10/23

12/23

PROGENITOR, NCT05953883: Proteogenomic Signatures Analysis In Ovarian Cancer

Active, not recruiting

N/A

Europe

Tumor and blood sample

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Ovarian Cancer

11/23

03/25

PROBE II, NCT05769517: PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Recruiting

N/A

1300

Europe

Germinal BRCA

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

BRCA Mutation, Ovarian Cancer, Ultrasound Therapy; Complications

04/24

05/26

SPEED, NCT06071286: SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS

Recruiting

N/A

Europe

Blood samples

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Ovarian Cancer

10/25

10/26

GEN&RARE, NCT06926127: Genomic Profiling of Genetic and Rare Diseases

Recruiting

N/A

1500

Europe

Whole Exome Sequencing (WES)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rare Diseases, Genetic Disease

04/26

02/30

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Cesari, Eleonari

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Pieraccioli, Marco

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Bottoni, Carolina

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Conte, Carmine

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Loverro, Matteo

TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting

N/A

Europe

Tumor biopsy, Blood sampling

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Organoids, Epithelial Ovarian Cancer

11/21

05/23

Iacovelli, Roberto

SELECTIO-UC, NCT06820255: DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.

Recruiting

135

Europe

Platinum + Gemcitabine, Avelumab first-line maintenance, NGS test for DDR alterations

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable, Upper Tract Urothelial Cancer

01/26

01/27

ITALIC-RCC, NCT06903312: Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

Not yet recruiting

409

Deferred Cytoreductive Nephrectomy + medical treatment, Radiotherapy + medical treatment, Medical therapy, Standard of Care (SOC)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, AIRC (Italian Association for Cancer Research)

Renal Cell Cancer, Kidney Neoplasm, Immunotherapy, Kidney Cancer, Surgery Programmed, Radiotherapy

10/27

04/28

Active, not recruiting

900

Europe, Canada, Japan, US, RoW

Abemaciclib, LY2835219, Abiraterone, Prednisone or Prednisolone, Placebo for Abemaciclib

Eli Lilly and Company

02/24

10/27

KEYNOTE-D74, NCT05911295: Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Recruiting

400

Europe, Canada, US, RoW

disitamab vedotin, RC48, RC48-ADC, pembrolizumab, KEYTRUDA®, gemcitabine, Gemzar, cisplatin, carboplatin

Seagen Inc., RemeGen Co., Ltd., Merck Sharp & Dohme LLC

Urothelial Carcinoma

06/26

04/29

PEACE6-Unfit, NCT04916613 / 2020-003663-26: ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Recruiting

300

Europe

Darolutamide 300 mg, Nubeqa®, Placebo, Androgen deprivation therapy, ADT

UNICANCER, Bayer

Prostate Cancer Metastatic

03/28

09/37

TIDE-A, NCT04698213: Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma

Recruiting

Europe

Axitinib Oral Tablet, Avelumab

Consorzio Oncotech, Clinical Research Technology S.r.l.

Renal Carcinoma Metastatic

09/23

10/24

CNN-BC, NCT05203913: Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer

Recruiting

Europe

Nivolumab, Opdivo, Nab paclitaxel, Abraxane, Cisplatin, CDDP, Radiotherapy, RT

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Muscle-Invasive Bladder Carcinoma

12/25

06/26

GDFather-NEO, NCT06059547 / 2022-002816-22: Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer

Active, not recruiting

Europe

Nivolumab, Visugromab (CTL-002), Placebo

CatalYm GmbH, CatalYm GmbH

Bladder Cancer, Adult Solid Tumor

08/25

09/26

PE-PE, NCT05578664 / 2022-001077-30: Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer

Recruiting

Europe

Pembrolizumab injection plus metastasis directed treatment (surgery or RT), Tumor resection or RT

Consorzio Oncotech, MERCK SHARP & DOHME LLC.

Oligometastatic Renal Cell Carcinoma

10/24

10/25

KEYNOTE-D78, NCT04879329: A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Recruiting

372

Europe, Canada, Japan, US, RoW

disitamab vedotin, RC48-ADC, pembrolizumab, KEYTRUDA®

Seagen, a wholly owned subsidiary of Pfizer, Merck Sharp & Dohme LLC

Urothelial Carcinoma

12/26

06/28

AxIn, NCT05817903 / 2022-001150-35: Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

Recruiting

118

Europe

Axitinib, Inlyta, Nivolumab

Consorzio Oncotech, Pfizer

Metastatic Renal Cell Carcinoma

04/26

04/27

SkinHealthOnco, NCT05878964: Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

Recruiting

N/A

420

Europe

EQ-5D-5L questionnaire, FACT-G (Functional Assessment of Cancer Therapy - General), FACT-EGFRI-18 (Functional Assessment of Cancer Therapy - Epidermal Growth Factor Inhibitors 18 Item)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lung Cancer, Breast Cancer, Kidney Cancer, Bladder Cancer, Gastric Cancer, Skin Cancer, Melanoma, Head Neck Cancer

07/25

09/25

PSA-DEEP02, NCT06652607: PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer

Recruiting

N/A

152

Europe

Enzalutamide, Apalutamide (Erleada™) 60 mg or 240 mg tablets, Darolutamide (Nubeqa®) 300 mg tablets, Taxotere (docetaxel), Abiraterone acetate + Prednisone or Prednisolone

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Prostate Cancer, Metastatic Cancer, Castrate Sensitive Prostate Cancer

11/26

04/28

Laurenti, Patrizia

CoVFlu, NCT05781191: Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine

Completed

N/A

8231

Europe

COMIRNATY, FLUAD TETRA, FLUCELVAX TETRA, FLUARIX TETRA

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Influenza, COVID-19

12/21

CeVOT-Her-Zo, NCT06334861: Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine Coverage

Completed

N/A

178

Europe

Herpes Zoster adjuvanted recombinant vaccine

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Herpes Zoster

05/24

07/24

SaniPhone, NCT06194903: Randomized Pilot Study Evaluating Isopropyl Alcohol and UVC Rays in Disinfection of Cell Phones

Completed

N/A

Europe

isopropyl alcohol wipes, UVC box

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cross Infection

03/24

04/24

CAREVAX, NCT06127563: Caring for Frail Patients Through Vaccination

Active, not recruiting

N/A

1500

Europe

creation of a clinical pathway to increase vaccination coverage in frail patients

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Vaccination Uptake

07/25

07/27

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites